text: SECTION 1. SHORT TITLE.
  
      This Act may be cited as the ``International Tuberculosis Control 
  Act of 2002''.
  
  SEC. 2. FINDINGS.
  
      Congress finds that:
              (1) Tuberculosis is a great health and economic burden to 
          impoverished nations and a health and security threat to the 
          United States and other industrialized countries.
              (2) Tuberculosis kills 2,000,000 people each year (a person 
          every 15 seconds) and is second only to HIV/AIDS as the 
          greatest infectious killer of adults worldwide.
              (3) Tuberculosis is today the leading killer of women of 
          reproductive age and of people who are HIV-positive.
              (4) One-third of the world's population is currently 
          infected with the tuberculosis bacterium, including 10,000,000 
          through 15,000,000 persons in the United States, and someone in 
          the world is newly infected with tuberculosis every second.
              (5) With 46 percent of tuberculosis cases in the United 
          States in the year 2000 found in foreign-born persons, as 
          compared to 24 percent in 1990, it is clear that the only way 
          to control tuberculosis in the United States is to control it 
          worldwide.
              (6) Left untreated, a person with active tuberculosis can 
          infect an average of 10 through 15 people in one year.
              (7) Pakistan and Afghanistan are among the 22 countries 
          identified by the World Health Organization as having the 
          highest tuberculosis burden globally.
              (8) More than one-quarter of all adult deaths in Pakistan 
          are due to tuberculosis, and Afghan refugees entering Pakistan 
          have very high rates of tuberculosis, with refugee camps, in 
          particular, being areas where tuberculosis runs rampant.
              (9) The tuberculosis and AIDS epidemics are inextricably 
          linked. Tuberculosis is the first manifestation of AIDS in more 
          than 50 percent of cases in developing countries and is 
          responsible for 40 percent or more of deaths of people with 
          AIDS worldwide.
              (10) An effective, low-cost cure exists for tuberculosis: 
          Directly Observed Treatment Short-course or DOTS. Expansion of 
          DOTS is an urgent global priority.
              (11) DOTS is one of the most cost-effective health 
          interventions available today. A full course of DOTS drugs 
          costs as little as US$10 in low-income countries.
              (12) Proper DOTS treatment is imperative to prevent the 
          development of dangerous multidrug resistant tuberculosis (MDR-
          TB) that arises through improper or incomplete tuberculosis 
          treatment.
              (13) The Global Fund to fight AIDS, Tuberculosis, and 
          Malaria is an important new global partnership established to 
          combat these 3 infectious diseases that together kill 6,000,000 
          people a year. Expansion of effective tuberculosis treatment 
          programs should constitute a major component of Global Fund 
          investment.
  
  SEC. 3. DEFINITIONS.
  
      In this Act:
              (1) DOTS.--The term ``DOTS'' or ``Directly Observed 
          Treatment Short-course'' means the World Health Organization-
          recommended strategy for treating standard tuberculosis.
              (2) Global alliance for tuberculosis drug development.--The 
          term ``Global Alliance for Tuberculosis Drug Development'' 
          means the public-private partnership that brings together 
          leaders in health, science, philanthropy, and private industry 
          to devise new approaches to tuberculosis and to ensure that new 
          medications are available and affordable in high tuberculosis 
          burden countries and other affected countries.
              (3) Global plan to stop tuberculosis.--The term ``Global 
          Plan to Stop Tuberculosis'' means the plan developed jointly by 
          the Stop Tuberculosis Partnership Secretariat and Partners in 
          Health that lays out what needs to be done to control and 
          eliminate tuberculosis.
              (4) Global tuberculosis drug facility.--The term ``Global 
          Tuberculosis Drug Facility (GDF)'' means the new initiative of 
          the Stop Tuberculosis Partnership to increase access to high-
          quality tuberculosis drugs to facilitate DOTS expansion.
              (5) Stop tuberculosis partnership.--The term ``Stop 
          Tuberculosis Partnership'' means the partnership of the World 
          Health Organization, donors including the United States, high 
          tuberculosis burden countries, multilateral agencies, and 
          nongovernmental and technical agencies committed to short- and 
          long-term measures required to control and eventually eliminate 
          tuberculosis as a public health problem in the world.
  
   SEC. 4. ASSISTANCE FOR TUBERCULOSIS PREVENTION, TREATMENT, CONTROL, 
                AND ELIMINATION.
  
      Section 104(c) of the Foreign Assistance Act of 1961 (22 U.S.C. 
  2151b(c)) is amended by adding at the end the following:
              ``(7)(A) Congress recognizes the growing international 
          problem of tuberculosis and the impact its continued existence 
          has on those countries that had previously largely controlled 
          the disease. Congress further recognizes that the means exist 
          to control and treat tuberculosis by implementing the Global 
          Plan to Stop Tuberculosis and by adequately investing in newly 
          created mechanisms, including the Global Tuberculosis Drug 
          Facility, and that it is therefore a major objective of the 
          foreign assistance program to control the disease. To this end, 
          Congress expects the agency primarily responsible for 
          administering this part--
                      ``(i) to coordinate with the World Health 
                  Organization, the Centers for Disease Control, the 
                  National Institutes of Health, and other organizations 
                  with respect to the development and implementation of a 
                  comprehensive tuberculosis control program; and
                      ``(ii) to set as a goal the detection of at least 
                  70 percent of the cases of infectious tuberculosis, and 
                  the cure of at least 85 percent of the cases detected, 
                  by December 31, 2005, in those countries classified by 
                  the World Health Organization as among the highest 
                  tuberculosis burden, and by December 31, 2010, in all 
                  countries in which the agency has established 
                  development programs.
              ``(B)(i) There is authorized to be appropriated 
          $200,000,000 for each of the fiscal years 2003 through 2005 for 
          carrying out this paragraph.
              ``(ii) Funds appropriated under this paragraph are 
          authorized to remain available until expended.
              ``(C) In carrying out subparagraph (A), not less than 75 
          percent of the amount authorized to be appropriated under 
          subparagraph (B) shall be expended for antituberculosis drugs, 
          supplies, patient services, and training in diagnosis and care, 
          in order to increase directly observed treatment shortcourse 
          (DOTS) coverage, including funding for the Global Tuberculosis 
          Drug Facility.
              ``(D) In carrying out subparagraph (A), of the amount 
          authorized to be appropriated under subparagraph (B)--
                      ``(i) not less than 10 percent shall be used for 
                  funding of the Global Tuberculosis Drug Facility;
                      ``(ii) not less than 7.5 percent shall be used for 
                  funding of the Stop Tuberculosis Partnership; and
                      ``(iii) not less than 2.5 percent shall be used for 
                  funding of the Global Alliance for Tuberculosis Drug 
                  Development.
              ``(E) The President shall submit a report to Congress 
          annually specifying the increases in the number of people 
          treated and the increases in number of tuberculosis patients 
          cured through each program, project, or activity receiving 
          United States foreign assistance for tuberculosis control 
          purposes.''.
target: International Tuberculosis Control Act of 2002 - Amends the Foreign Assistance Act of 1961 to revise requirements for assistance for health programs in developing countries to declare that Congress recognizes that the means exist to control and treat the growing international problem of tuberculosis by implementing the Global Plan to Stop Tuberculosis and investing in new mechanisms like the Global Tuberculosis Drug Facility. Makes it a major objective of the foreign assistance program to control the disease.Declares that Congress expects the agency primarily responsible for administering this Act to: (1) coordinate with the World Health Organization (WHO), the Centers for Disease Control, the National Institutes of Health, and other organizations with respect to the development and implementation of a comprehensive tuberculosis control program; and (2) set specified deadlines for the detection of at least 70 percent of the cases of infectious tuberculosis, and the cure of at least 85 percent of them.Earmarks specified amounts of funds for antituberculosis drugs, supplies, patient services, and training in diagnosis and care in order to increase directly observed treatment shortcourse (DOTS) coverage, including funding for the Global Tuberculosis Drug Facility.
feat_title: A bill to amend the Foreign Assistance Act of 1961 to take steps to control the growing international problem of tuberculosis.